Clinical Trial: Phase 1 Study of ADX-626 in Healthy Participants

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07081503) titled 'Phase 1 Study of ADX-626 in Healthy Participants' on July 03.

Brief Summary: This first-in-human study will evaluate the safety and tolerability of ADX-626 in healthy participants. The study will also look at how ADX-626 interacts with the human body (the pharmacokinetics and pharmacodynamics of ADX-626).

Study Start Date: July 14

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: ADX-626

siRNA duplex oligonucleotide

DRUG: Placebo

Saline

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ADARx Pharmaceuticals, Inc.

Disclaimer: Curated by HT Syndication....